US: Unaffordable Insulin Endangers Lives

Click to expand Image Zoe Witt, a type 1 diabetic in Seattle, Washington, holds a 10-milliliter vial of Novolog, a name-brand insulin analog produced by the Danish company Novo Nordisk. © 2022 Bella Petro (Washington, DC) – The US government’s failure to ensure equal and affordable access to insulin violates the right to health for people with diabetes and regularly leads to tragic consequences for many of them, Human Rights Watch said in a report released today. The 92-page report, “‘If I’m Out of Insulin, I’m Going to Die:’ United States’ Lack of Regulation Fuels Crisis of Unaffordable…

© Human Rights Watch - mardi 12 avril 2022